IMO, it's positive that a Type C meeting was granted and neutral-positive that IXC requested a Type B and were granted a Type C.
I'm leaning towards this being great news for the reasons outlined by @jellyroll. I don't necessarily agree that WRO is a bad thing in the current climate. It could very well mean that this is a straightforward case, given the Type 2 data, detailed statistical plan and EMA advice. Thus, IXC may only require written responses without additional guidance.
I also think the share price has factored in much of the worst case scenario - i.e., two trials are required by the FDA. I don't expect the SP to touch $0.40, but I guess anything is possible. Nothing about the market makes sense today.
@ralom - agree that it's frustrating, but we'll soon find out the reasons for the delay. This quarter is going to be a big one.
- Forums
- ASX - By Stock
- Ann: Invex Granted Type C Meeting with FDA
IMO, it's positive that a Type C meeting was granted and...
-
- There are more pages in this discussion • 118 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.2¢ |
Change
0.002(2.86%) |
Mkt cap ! $5.411M |
Open | High | Low | Value | Volume |
7.2¢ | 7.2¢ | 7.2¢ | $1.701K | 23.62K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 76375 | 7.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 76375 | 0.072 |
1 | 52915 | 0.070 |
1 | 84879 | 0.067 |
1 | 100000 | 0.066 |
1 | 50000 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 5000 | 1 |
0.085 | 8805 | 1 |
0.090 | 126146 | 1 |
0.095 | 100000 | 1 |
0.100 | 8505 | 2 |
Last trade - 15.42pm 13/09/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online